Tirzepatide—often labeled as GLP-1 T 30MG or GLP-1 T 20MG in compounded forms—is a powerful injectable medication that works by mimicking two natural gut hormones: GLP-1 and GIP.
Tirzepatide is a dual-action injectable medication that targets:
GLP-1 (Glucagon-Like Peptide-1): Regulates blood sugar and appetite.
GIP (Glucose-Dependent Insulinotropic Polypeptide): Enhances insulin sensitivity and complements GLP-1 effects.
This dual mechanism makes tirzepatide more effective than GLP-1 agonists alone for weight loss and blood sugar control.
What Tirzepatide Does in the Body:
Regulates Blood Sugar
Stimulates insulin release when blood sugar is high.
Suppresses glucagon, a hormone that raises blood sugar.
Slows digestion, which helps prevent blood sugar spikes after meals.
Promotes Weight Loss
Reduces appetite by acting on brain centers that control hunger.
Slows gastric emptying, making you feel full longer.
Clinical trials show 15–20% body weight reduction over 72 weeks.
Improves Metabolic Health
Enhances insulin sensitivity.
May reduce cholesterol, blood pressure, and inflammation.
Shown to help with fatty liver disease and obstructive sleep apnea.
Supports Long-Term Wellness
May reduce risk of heart failure, cardiovascular events, and progression to type 2 diabetes in people with prediabetes.
Helps maintain weight loss when combined with diet and exercise.
GLP-1 T 20MG - TIRZEPATIDE
WHAT IT IS
HOW IT WORKS
POTENTIAL BENEFITS
DISCLAIMER
Tirzepatide is the first medication to combine both GLP-1 and GIP receptor activation. This dual action makes it more effective than GLP-1 drugs alone (like semaglutide) for both blood sugar control and weight loss.
What Tirzepatide Does:
Controls Blood Sugar
-
Stimulates insulin release when blood sugar is high.
-
Suppresses glucagon, which reduces sugar production by the liver.
-
Helps lower both fasting and post-meal glucose levels.
Promotes Weight Loss
-
Slows gastric emptying, so food stays in your stomach longer.
-
Reduces appetite by acting on brain centers that control hunger.
-
Clinical trials show 15–20% body weight reduction over 72 weeks2.
Improves Metabolic Health
-
Enhances insulin sensitivity, helping your body use insulin more effectively.
-
May reduce cholesterol, blood pressure, and inflammation.
-
Shown to help with fatty liver disease, sleep apnea, and cardiovascular risk.
Supports Long-Term Wellness
-
In people with prediabetes, tirzepatide reduced the risk of progressing to type 2 diabetes.
-
In one study, 99% of participants remained diabetes-free after 3 years of treatment.